GGrantIndex
Sort

11,323 grants matching glioblastoma

Utilizing Radiation-Induced Multi-potency to Increase the Efficacy of Radiotherapy

$484,078
Frank Pajonk · University Of California Los Angeles · R01 · FY2024 · CA

Project 4: Clinical translation and validation of metabolic probes to evaluate brain tumors

$483,926
Yan Li · University Of California, San Francisco · P01 · FY2025 · CA

Project 4: Clinical translation and validation of metabolic probes to evaluate brain tumors

$483,926
Yan Li · University Of California, San Francisco · P01 · FY2024 · CA

Chitinase-3-like-1 mediated immunosuppression in Glioblastoma

$483,859
Baoli Hu · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · CA

Neoadjuvant checkpoint blockade for recurrent glioblastoma

$483,557
Robert M Prins · University Of California Los Angeles · R01 · FY2023 · CA

Efficacy of PDI inhibitors in glioblastoma

$483,547
Nouri Neamati · University Of Michigan At Ann Arbor · R01 · FY2018 · CA

Evaluating microtubule binding as a potential imaging biomarker for Alzheimer's disease

$483,320
Kiran Solingapuram Sai · Wake Forest University Health Sciences · R01 · FY2022 · AG

Targeted Photoactivable Nanocells: Image-based Drug Delivery and Dosimetry in GBM

$482,872
Tayyaba Hasan · Massachusetts General Hospital · R01 · FY2014 · CA

Therapeutic targeting of the SWI/SNF chromatin remodeler to regulate GBM chemosensitivity

$482,829
Lawrence M Pfeffer · University Of Tennessee Health Sci Ctr · R01 · FY2024 · CA

Targeting Neoantigens in Glioblastoma

$482,595
Gavin Peter Dunn · Massachusetts General Hospital · R01 · FY2023 · NS

MDA-7/IL-24: Therapy of Prostate Cancer

$482,536
Paul B Fisher · Virginia Commonwealth University · P01 · FY2008 · CA

Computational Approaches for RNA StructureFunction Determination

$482,357
Bruce Shapiro · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA

Develop novel therapeutic strategy for brain tumor

$482,273
Chun Zhang Yang · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA

AHR-mediated immunosuppression in glioblastoma

$482,198
Francisco J. Quintana · Brigham And Women'S Hospital · R01 · FY2020 · ES

Cellular Transduction with Replication-Competent Retrovirus Vectors

$481,936
Noriyuki Kasahara · University Of California Los Angeles · R01 · FY2009 · CA

Role of NKCC1 on Brain Tumor Stem Cell Migration After EGF and Slit-2 Stimulation

$481,753
Alfredo Quinones-Hinojosa · Johns Hopkins University · R01 · FY2011 · NS

Systemic Delivery of Targeted Bi-Compartmental Nanoparticles for Glioblastoma Therapeutics

$481,602
Joerg Lahann · University Of Michigan At Ann Arbor · R01 · FY2023 · NS

Controlled Release of Multiple Drugs from Electrospun Fiber Membranes in the Local Treatment of Glioblastoma

$481,543
Andrew Jules Steckl · University Of Cincinnati · R15 · FY2020 · CA

Tumor Microenvironment in Modulating the Primary & Metastatic Brain Tumors

$481,506
Johanna Joyce · Sloan-Kettering Inst Can Research · U54 · FY2009 · CA

Blood-brain barrier disruption with implantable ultrasound to enhance paclitaxel delivery: A Phase 1-2 clinical trial in recurrent glioblastoma

$481,500
Adam M Sonabend · Northwestern University At Chicago · R01 · FY2023 · CA

Targeting oncogenic dopamine receptor signaling in glioblastoma

$481,289
Jeongwu Lee · Cleveland Clinic Lerner Com-Cwru · R01 · FY2021 · CA

Development of SHP2 inhibitors for targeted anti-cancer therapy

$481,271
Zhong-Yin Zhang · Purdue University · R01 · FY2017 · CA

Development of Parametric Response Mapping Software for Clinical Cancer Response Assessment

$480,745
Lauren Keith · Imbio, Llc · R44 · FY2019 · CA

Academic-Industrial Partnership to Develop Clinical Brain Cancer Imaging

$480,667
Jinyuan Zhou · Johns Hopkins University · R01 · FY2017 · CA

Salicylic acid-based small-molecule Stat3 inhibitors for anticancer therapy

$480,634
James K Turkson · University Of Hawaii At Manoa · R01 · FY2016 · CA